OncLive | Bringing the Global Oncology Community Together

Education ▼

Conference Coverage

NewsNetwork

OncLive TV

PEER EXCHANGE

OncLive INSIGHTS

Join us for a LIVE, interactive broadcast on NSCLC Friday 10/5

SPECIALTY TOPICS

CURRENTLY VIEWING
All Specialties

Gastrointestinal Cancer

Latest News

Expert Addresses Advances and Challenges in Myeloma

Andrew Kin, MD, shares his insight on the treatment landscape for multiple myeloma and the challenges that remain. Read More >>

CAR T-Cell Therapy Brings Hope to Relapsed/Refractory Myeloma

Diagnosis of ITP Remains a Challenge for Clinicians

CLL Paradigm Continues to Be Refined

Hurvitz Evaluates De-Escalation Strategies in Early-Stage HER2+ Breast Cancer

Expert Addresses Oncology Costs, Potential Impact of Biosimilars

View More Stories >>

View Conference Coverage

2018 International Liver Cancer Association Annual Conference

2018 International Lung Cancer Congress

2018 Pan Pacific Lymphoma Conference

2nd Annual Live Medical Crossfire® : Hematologic Malignancies

State of the Science Summit on A Summer of Progress: Updates from ASCO 2018

Dr. Shah on Treatment of Patients with p53-Mutated MCL

Dr. Bunn on the Treatment of Early-Stage Lung Cancer

Dr. Konecny on the Value of PARP Inhibitors in Ovarian Cancer

Dr. Sonpavde on Remaining Questions With Immunotherapy in Bladder Cancer

Dr. Ali on Adjuvant Studies With Biosimilars in Oncology

Dr. Eng Discusses the ADORE Trial in Rectal Cancer

Dr. Dent Discusses Ipatasertib in Triple-Negative Breast Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

Recognizing HCC Risk Factors

HCC Staging Systems Explored

PARP Combination Therapies in Ovarian Cancer

Future Outlook: Treating Advanced Melanoma

Ongoing PARP Trials in Recurrent Ovarian Cancer

Emerging Combination Regimens in Advanced Melanoma

OncLive houses thousands of videos that provide updates and information.
See more Videos

TKI/I-O Therapy in mRCC

Therapeutic Sequencing in mRCC

Managing Patients on Lenvatinib/Everolimus in mRCC

Future of CDK4/6 Inhibition in HR+ Breast Cancer

$Lenvatinib and Everolimus in Relapsed/Refractory mRCC$

Abemaciclib Monotherapy's Role in HR+ Breast Cancer

Optimizing CDK4/6 Inhibition in HR+ Breast Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured

NTRK Gene Fusions: Novel Targets for Tumor-Agnostic Cancer Therapy

Over the past few decades, our knowledge of the role of gene mutations in oncogenesis has transformed cancer care.

View more >>>

Featured

Dr. Ramchandren on the North American Results of the ECHELON-1 Study in Hodgkin Lymphoma

Radhakrishnan Ramchandren MD, associate professor, Wayne State University School of Medicine, Barbara Ann Karmanos Cancer Institute, discusses the North American results of the ECHELON-1 study in Hodgkin lymphoma.

View more >>>

Featured Video

Immunotherapy in the Treatment of Follicular Lymphoma

Ian W. Flinn, MD, PhD; Grzegorz S. Nowakowski, MD; Loretta J. Nastoupil, MD; and Anas Younes, MD, reflect on the value of immunotherapy, immunotherapy combination strategies, and understanding the tumor microenvironment in treating follicular lymphoma.View now

Priority Review in NSCLC, Label Update in CLL, Delayed FDA Decision in Lung Cancer, and More